Mathematica Policy Research, Inc., 1100 1st Street NE, Washington, DC 20002, USA.
Neurosurg Focus. 2012 Jul;33(1):E7. doi: 10.3171/2012.4.FOCUS12106.
Containing growth in health care expenditures is considered to be essential to improving both the long-term fiscal outlook of the federal government and the future affordability of health care in the US. As health care expenditures have increased, so too have concerns about the quality of health care. Better information on the clinical effectiveness of alternative treatments and other interventions is needed to improve the quality of care and restrain growth in expenditures. This article explains the key role played by the federal government in defining the context and process of comparative effectiveness research as well as its funding. Subsequently, the article explores the mission, priorities, and research agenda of the Patient-Centered Outcomes Research Institute, which is an independent, nonprofit corporation established in 2010 by the Patient Protection and Affordable Care Act.
控制医疗保健支出的增长被认为对于改善联邦政府的长期财政前景以及美国未来医疗保健的可负担性至关重要。随着医疗保健支出的增加,人们对医疗保健质量的担忧也越来越多。为了提高医疗服务质量和控制支出增长,需要更好地了解替代治疗方法和其他干预措施的临床效果信息。本文解释了联邦政府在定义比较效果研究的背景和过程及其资金方面所发挥的关键作用。随后,本文探讨了 2010 年《患者保护与平价医疗法案》设立的一个独立的非营利性组织——患者中心的结果研究所的使命、优先事项和研究议程。